Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on April 4, 2025
Global Clinical Trials Support Services Market to Reach USD 46.2 Billion by 2033 Rising R&D Investments
EIN Presswire
·
April 4, 2025
The Clinical Trials Support Services Market is expected to grow from an estimated USD 21.3 billion in 2024 to USD 46.2 billion in 2033, at a CAGR of 8.00%. VANCOUVER, BRITISH COLUMBIA, CANADA, April 4, 2025 /EINPresswire.com/ -- The research may be …
Global Bioprosthetics Market Increasing Size, Demand, Growth Rate, and Forecast 2033 - Emergen Research
EIN Presswire
·
April 4, 2025
The advancements in medical technology the increasing prevalence of chronic conditions like cardiovascular diseases osteoarthritis are further propelling VANCOUVER, BRITISH COLUMBIA, CANADA, April 4, 2025 /EINPresswire.com/ -- Emergen Research's …
AIM ImmunoTech Announces NYSE American Notice of Delisting and Appeal
GlobeNewswire
·
April 4, 2025
OCALA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (“AIM” or the “Company”) (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and …
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
WALTHAM, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that, …
Jade Guerra Warns of Increasing Migraine Cases Tied to Digital Overuse
EIN Presswire
·
April 4, 2025
Jade Guerra, a chiropractic expert and registered nurse. She warns that more people are getting migraines because of too much screen time. DALLAS, TX, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- As more people spend time on digital devices, …
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
CAMBRIDGE, Mass., April 04, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high …
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
·
April 4, 2025
NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that on April 1, 2025 the Company granted inducement …
Bioprocess Optimization and Digital Bio-manufacturing Market Forecast 2029
GlobeNewswire
·
April 4, 2025
Boston, April 04, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Bioprocess Optimization and Digital Bio-manufacturing: Global Markets” is expected to grow from $24.3 billion in 2024 to $39.6 billion by the end of 2029 at a …
American Nurses Enterprise Names New Chief Nursing Officer
GlobeNewswire
·
April 4, 2025
SILVER SPRING, MD, April 04, 2025 (GLOBE NEWSWIRE) -- The American Nurses Enterprise, which includes the American Nurses Association, the American Nurses Credentialing Center, and the American Nurses Foundation, is pleased to announce the appointment of …
Dr. Jonathan Odinsky of Infinity Dental Wellness Awarded As 2024 NJ Top Dentist
EIN Presswire
·
April 4, 2025
NJ Top Dentists has reviewed and approved Dr. Jonathan Odinsky of Infinity Dental Wellness based on merit for 2024. FORT LEE, NJ, UNITED STATES, April 4, 2025 /EINPresswire.com/ -- NJ Top Dentists has reviewed and approved Dr. Jonathan Odinsky of …
Energetic Harmony Expands Holistic Stress Relief Services with Emotion Code for Professionals Facing Chronic Stress or Past Trauma
GlobeNewswire
·
April 4, 2025
TAMPA BAY, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Energetic Harmony℠, a leader in holistic stress relief, proudly announces the expansion of its services to include Emotion Code—a powerful modality specifically designed to help age 30+ professionals …
Better Choice Company Chairman Provides Shareholder Update on SRx Health Acquisition and Comments on Recent Debt-to-Equity Transaction
GlobeNewswire
·
April 4, 2025
TAMPA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, Chairman, Michael Young, today provides shareholders with a update on its SRx Health …
Better Choice Company Signs Definitive Agreement for SRx Health Solutions to Convert CAD$4 Million in Debt to Equity
GlobeNewswire
·
April 4, 2025
TAMPA, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, is pleased to announce that SRx Health Solutions, Inc. (“SRx Health”) has signed a …
Sonnet’s SON-1010 Demonstrates a Strong Safety Profile in Combination with Atezolizumab for Treatment of Platinum-Resistant Ovarian Cancer, Including a Partial Response at the Highest Dose
GlobeNewswire
·
April 4, 2025
Topline safety data in SB221 study suggest clinical benefit of SON-1010 in combination with atezolizumab (Tecentriq®) The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg in combination with atezolizumab in patients with platinum-resistant …
NeuroOne Medical Technologies Corporation Announces Pricing of $8.0 Million Public Offering of Common Stock
GlobeNewswire
·
April 4, 2025
EDEN PRAIRIE, Minn., April 04, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the “Company”), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological …
Tr1X Awarded $8 Million CIRM Grant to Support TRX103 Phase 1/2a Clinical Trial for Graft-Versus-Host Disease
GlobeNewswire
·
April 4, 2025
SAN DIEGO, April 04, 2025 (GLOBE NEWSWIRE) -- Tr1X, Inc. (pronounced “Trix”), a clinical-stage biopharmaceutical company developing first-in-class allogeneic engineered Treg and CAR-Treg cell therapies with the potential to cure autoimmune and inflammatory …
Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee
GlobeNewswire
·
April 4, 2025
PALO ALTO, Calif., April 04, 2025 (GLOBE NEWSWIRE) -- Kalaris Therapeutics, Inc. (Nasdaq: KLRS) (“Kalaris”), a clinical-stage biopharmaceutical company dedicated to the development and commercialization of treatments for prevalent retinal diseases, today …
EluPro™ Named as 2025 Edison Award Winner
GlobeNewswire
·
April 4, 2025
Innovative Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Pacemakers and Neurostimulators Earns Bronze in Post-Surgical Recovery Solutions Category SILVER SPRING, Md., April 04, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia …
Palvella Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference
GlobeNewswire
·
April 4, 2025
WAYNE, Pa., April 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare …
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
GlobeNewswire
·
April 4, 2025
MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregate capacity of …